Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive November 1, 2013	Roundtable on Market Access Market Access is a window on what matters in the real world of soaring patient expectations and crimped payer budgets for innovation.
Nursing Management October 2011 Edna Cadmus	Your role in redesigning healthcare We need to rethink how we provide care and to understand the interconnectedness and the structure of healthcare by looking at it as a whole vs. the sum of its parts. As leaders we need to view the evidence as we rethink healthcare together.
Pharmaceutical Executive July 1, 2013 Richie Etwaru	Innovation Calls Across the C-suite: Lessons From Wall Street The lifeblood of the life sciences industry is continuous innovation; it is not a business that can survive by standing still.
Pharmaceutical Executive March 1, 2012 Paolo De Marino	Registering Value: Always in the Eye of the Beholder The organizational disconnect between marketing and market access is curable if both groups focus on what counts: who's making the final purchase.
Managed Care August 2006 Emad Rizk	Finding Opportunity Where Business Models Meet The next stage of payer-provider collaboration will add true value.
Pharmaceutical Executive February 1, 2014 Anbil et al.	Managed Markets: Positioning Your Product For Success with Pull Through Strategies A patient-centric approach to drug development delivers the benefits that actually create value
Pharmaceutical Executive October 1, 2010	When the Payer IS the Player As Medicare, Medicaid, and the nation's web of private payers gain market power, how can pharma stay ahead of the cost-containment curve?
Pharmaceutical Executive February 1, 2012 Wilcox et al.	Sales Force Survey: Still Too Much Business as Usual? In the global battle for market share, the ability to adapt and mobilize your human assets around a responsive commercial model is a key variable of success.
Nursing Management September 2008 Richard Hader	Strategies for profitable growth Experience has demonstrated that a focus on expense reduction alone won't sustain or improve financial stability in health care services.
Pharmaceutical Executive March 1, 2013 Forcellina & Akannac	Embedding Market Access in Today's Pharma Business Model A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.
Pharmaceutical Executive March 1, 2014 William Looney	The Call to Community: A Conversation with Dr. David Nash Population health is the foundation for much of what is truly new in US health reform. For big Pharma, it represents yet another escalation in expectations.
Pharmaceutical Executive July 1, 2012 William Looney	The Learning Curve In a wake up call to this year's Emerging Leaders a group of St. Joseph's Business School Health Management alumni say time has no limit on surprises; change for pharma is here and it's good.
Pharmaceutical Executive April 1, 2014 William Looney	The Trials of Commerce Four commercial line executives serve as our jury of peers on what's in store for the future of pharma, and discuss the changing criteria for market success, from drugs to consumer products to vaccines.
Pharmaceutical Executive August 1, 2011 William Looney	Innovation at Pfizer A Q and A with Kristin Peck, the drug maker's Executive Vice President, Worldwide Business Development and Innovation.
Pharmaceutical Executive January 1, 2012 William Looney	Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
HBS Working Knowledge June 7, 2004 Cross & Parker	How Org Charts Lie In an excerpt from Harvard Business School Press' Hidden Power of Social Networks, learn how "social network analysis" reveals problems your org chart ignores.
Pharmaceutical Executive September 1, 2011 Richard Gliklich	The Power of Observation Observational studies present a compelling real-world corollary to the classic randomized clinical trial.
Pharmaceutical Executive August 1, 2014 William Looney	A Mission to Transform Mid-career students at Brown University's new Executive Masters in Healthcare Leadership program are challenging the status quo with workplace projects focused on one thing: removing the organizational silos.
Managed Care January 2004	Major legislative reform not in store for 2004 It appears that health care reform will reside with health care organizations, according to a new Cap Gemini Ernst & Young forecast.
Nursing Management November 2007 Carrick et al.	Rapid-Fire Strategies for Regulatory Readiness The public opinion plays a key role in determining whether or not caregivers and hospitals are safe, high-quality providers.
Managed Care February 2002 Ira Studin	Reframing the Pharmaceutical Manufacturer/Health Plan Relationship in Managed Care It is suggested that health plans address "total cost-of-care savings" in their budget process, and the pharmaceutical manufacturers establish a "consultative service function" in their managed care divisions...
Pharmaceutical Executive May 1, 2006 Stephen Wray	Alternative Media: Interactive=Integration Interactive technology allows marketers to keep up with the demands of both physicians and consumers.
Nursing Management September 2009 Richard Hader	Six Ways to Zero Defects Care delivery that's safe, effective, patient-centered, timely, efficient, and equitable is the challenge set forth by the Institute of Medicine in an effort to reduce medical-related errors
Pharmaceutical Executive August 1, 2012 Andrea Sobrio	Innovative Contracting: What is the Verdict? Industry is finding it harder to secure market access and payer uptake for new products. Innovative contracting may offer a solution. Is it working?
Pharmaceutical Executive September 1, 2011 Richard Barker	Innovating Around Innovation The former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Pharmaceutical Executive November 1, 2014	Sales Reps and the New Commercial Organization By rethinking the role of the sales rep and the new skills it demands, pharma companies can put themselves in a prime competitive position.
HBS Working Knowledge April 23, 2007 Sarah Jane Gilbert	Are Great Teams Less Productive? There are built-in tensions between learning and performance, which smart organizations must learn to recognize and deal with.
Nursing Management September 2010 Richard Hader	The evidence that isn't... Interpreting research When patients seek a healthcare practitioner for services, they believe that the delivered care is based on proven science. But reality is far from patient perception. In fact, most care is still based on anecdote, not evidence.
Pharmaceutical Executive February 1, 2013 William Looney	Pathways to Progress Cancer is increasingly understood as a collection of rare and mostly treatable conditions rather than the impregnable, monolith portrayed in popular culture. Industry experts review current and pending efforts to turn great science into good practice.
Insurance & Technology October 20, 2009 Chuck Cornelio	Secrets of IT Talent Management: Workforce Risks Worth Taking Sometimes the less obvious candidates are the right ones when it comes to selecting your IT leadership team.
Nursing Management April 2009 Sharon H. Pappas	Profits, Payers, and Patients: Responding to Changes Profit is necessary for hospitals to fulfill their missions, invest in expansion and new technologies, and reinvest in existing patient care infrastructures. Profitability is the work of the financial team and the clinical team to produce the hospital's desired financial outcome.
Pharmaceutical Executive September 1, 2011	Should the US Gamble with Risk Sharing? Especially when payers come to the table holding the best cards, leaving industry second-guessing its strategy.
Fast Company November 2004 Linda Tischler	IBM's Management Makeover As its world changes, IBM is studying its top-performing leaders. What do they do differently, and can everyone do it?
Global Services August 14, 2008 Mehra & Singh	A Comprehensive Talent Strategy for Services Outsourcing Outsourced service operations in India, China, and other developing countries face a war for talent that will ultimately determine their competitiveness. Win this war by pursuing a comprehensive talent-management strategy.
Pharmaceutical Executive February 1, 2012 Sarah Krug	Introducing the 'Chief Patient Officer' Now is the time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust.
Parameters Autumn 2004 George Reed et al.	Mapping the Route of Leadership Education: Caution Ahead A networked approach to joint leadership development can lead to multiple perspectives of leadership more appropriate to a rapidly changing environment and one more worthy of the military profession.
HBS Working Knowledge July 12, 2006 Roger Thompson	Competition the Cure for Healthcare Michael Porter is considered by many the world's foremost authority on competition and strategy. So when he discusses the need for fundamental reform in the way the United States delivers healthcare, people listen.
Pharmaceutical Executive September 1, 2014 Pierre Morgon	Medical Affairs: From Info Gatekeeper to Legitimate Value Driver The role of pharma medical affairs teams is taking on greater importance in the value chain.
Pharmaceutical Executive June 1, 2014 O'Connor et al.	Challenges to the Specialty Business Model New constraints require new solutions. Innovative, value-based pricing models will be critical to securing reimbursement and continued market access of high-price drugs.
Managed Care September 2007 Martin Sipkoff	Go Carefully When Measuring Quality Gauging and rewarding good work in health care is a noble goal with potentially negative consequences.
Nursing Management April 2012 Gloria Kersey-Matusiak	Culturally competent care: Are we there yet? What exactly is culturally competent care, and how can you use it to lessen healthcare disparities among your patients?
Pharmaceutical Executive July 1, 2009	Swallowing the Innovator's Rx Capitalize on the new age in healthcare with "disruptive innovation."
CRM July 1, 2007 Marshall Lager	Market Focus: Healthcare: The Great Divide The healthcare industry continues to have issues defining itself and its approach to CRM - but that's because it's more than one industry: the business of medicine and the care of patients.
Pharmaceutical Executive March 1, 2009 Brittany Agro	The New Sales Force The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with, and how it's working.
Pharmaceutical Executive March 3, 2014 Mason Tenaglia	The New Metrics of Market Success Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else?
HBS Working Knowledge August 18, 2003 Linda A. Hill	How New Managers Become Great Managers Newly minted managers must commit themselves to lifelong self-improvement. This article is an excerpt from Harvard Business School professor Linda A. Hill's update of her classic, Becoming a Manager.
Pharmaceutical Executive August 1, 2012 Pascheles & Bogan	The Ultimate Business Model: Planning that Thousand Year Future In an era where success is monitored and measured in microseconds, planning for the long term is increasingly seen as an abstract absurdity. Yet the principles of natural selection, when applied to the pharmaceutical business, suggest that a lasting business model is still possible.
Pharmaceutical Executive June 1, 2009	Pay For Play The P4P movement is here. Pharma marketers, it's time to take note.
Pharmaceutical Executive July 1, 2012 Al Topin	Marketing: Why the Conversation Has Changed -- Forever At its core, pharma marketing is about conversations. Dynamic, persuasive conversations between companies and healthcare stakeholders. But one time it was simple; now it's not.
Knowledge@Wharton January 15, 2003	Why Some Companies Succeed at CRM (and Many Fail) What makes some companies so much better at managing customer relationships than their competitors? New research suggests three distinct approaches to customer relationship management (CRM), each with dramatically different results.